These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 11562757)

  • 1. CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity.
    Vonderheide RH; Butler MO; Liu JF; Battle TE; Hirano N; Gribben JG; Frank DA; Schultze JL; Nadler LM
    Int J Oncol; 2001 Oct; 19(4):791-8. PubMed ID: 11562757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals.
    Yellin MJ; Brett J; Baum D; Matsushima A; Szabolcs M; Stern D; Chess L
    J Exp Med; 1995 Dec; 182(6):1857-64. PubMed ID: 7500031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
    Chaperot L; Plumas J; Jacob MC; Bost F; Molens JP; Sotto JJ; Bensa JC
    Exp Hematol; 1999 Mar; 27(3):479-88. PubMed ID: 10089910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
    Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
    J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell costimulation via CD28-CD80/CD86 and CD40-CD40 ligand interactions.
    Somoza C; Lanier LL
    Res Immunol; 1995; 146(3):171-6. PubMed ID: 8525049
    [No Abstract]   [Full Text] [Related]  

  • 9. Impairment of T-cell activation in head and neck cancer in situ and in vitro: strategies for an immune restoration.
    Lang S; Whiteside TL; Lebeau A; Zeidler R; Mack B; Wollenberg B
    Arch Otolaryngol Head Neck Surg; 1999 Jan; 125(1):82-8. PubMed ID: 9932594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice.
    Holländer GA; Castigli E; Kulbacki R; Su M; Burakoff SJ; Gutierrez-Ramos JC; Geha RS
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4994-8. PubMed ID: 8643517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
    Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C
    Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD54/intercellular adhesion molecule 1 and major histocompatibility complex II signaling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation.
    Poudrier J; Owens T
    J Exp Med; 1994 May; 179(5):1417-27. PubMed ID: 7513009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules.
    Van den Hove LE; Van Gool SW; Vandenberghe P; Bakkus M; Thielemans K; Boogaerts MA; Ceuppens JL
    Leukemia; 1997 Apr; 11(4):572-80. PubMed ID: 9096698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.
    Van Gool SW; Vandenberghe P; de Boer M; Ceuppens JL
    Immunol Rev; 1996 Oct; 153():47-83. PubMed ID: 9010719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation.
    Cella M; Scheidegger D; Palmer-Lehmann K; Lane P; Lanzavecchia A; Alber G
    J Exp Med; 1996 Aug; 184(2):747-52. PubMed ID: 8760829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of dendritic cells in T cell activation.
    Ni K; O'Neill HC
    Immunol Cell Biol; 1997 Jun; 75(3):223-30. PubMed ID: 9243286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human duodenal epithelial cells constitutively express molecular components of antigen presentation but not costimulatory molecules.
    Byrne B; Madrigal-Estebas L; McEvoy A; Carton J; Doherty DG; Whelan A; Feighery C; O'Donoghue DP; O'Farrelly C
    Hum Immunol; 2002 Nov; 63(11):977-86. PubMed ID: 12392850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
    Ranheim EA; Kipps TJ
    J Exp Med; 1993 Apr; 177(4):925-35. PubMed ID: 7681471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro.
    Pettit SJ; Ali S; O'Flaherty E; Griffiths TR; Neal DE; Kirby JA
    Clin Exp Immunol; 1999 Apr; 116(1):48-56. PubMed ID: 10209504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.